Ursula Wiedermann
Medizinische Universität Wien
H-index: 50
Europe-Austria
Top articles of Ursula Wiedermann
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Complete genome sequence of Bordetella parapertussis strain 400431-b, isolated from a protracted course of whooping cough in Austria, 2023 | Microbiology Resource Announcements | Maria João Cardoso David Rouhani Adriana Cabal Rosel Beatriz Daza Prieto Miriam Hopfgartner | 2024/1/17 |
Abstract CT215: Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific … | Cancer Research | Joshua Tobias Michael Kundi Erika Garner-Spitzer Christoph Zielinski Marina Maglakelidze | 2024/4/5 |
Aktualisierung der COVID-19-Impfempfehlung in den allgemeinen Empfehlungen der STIKO 2024 und die dazugehörige wissenschaftliche Begründung | Vanessa Piechotta Judith Koch Reinhard Berner Christian Bogdan Gerd Burchard | 2024/1/11 | |
Empfehlungen der Ständigen Impfkommission (STIKO) und der Deutschen Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit eV (DTG) zu Reiseimpfungen. | Kerstin Kling Wiebe Külper-Schiek Camilla Rothe Gerhard Boecken Christian Bogdan | 2024/4/4 | |
Breakthrough Infections in SARS-CoV-2 Vaccinated Multiple Myeloma Patients Lead to Non-Severe COVID-19 and Broadened Long-Term Immunity to Variants of Concern | Angelika Wagner Erika Garner-Spitzer Claudia Auer Pia Gattinger Ines Zwazl | 2024 | |
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains | Vaccines | Al Nasar Ahmed Sehgal Jera Safran Bernhard Kratzer Pia Gattinger Robert B Stieger | 2024/4/1 |
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance | Allergy | Nora Geissler Maria Orola Masoumeh Alinaghi Alexander Nardo Thomas M Stulnig | 2024/2 |
Empfehlung zur Standardimpfung von Säuglingen gegen Meningokokken der Serogruppe B und die dazugehörige wissenschaftliche Begründung | Vanessa Piechotta Judith Koch Christian Bogdan Heike Claus Gerd Burchard | 2024/1/18 | |
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy | Journal of Clinical Virology | Daniela Sieghart Claudia A Hana Caroline Dürrschmid Leonhard X Heinz Helmuth Haslacher | 2024/8/1 |
Wissenschaftliche Begründung der STIKO zur Entscheidung, den COVID-19-Impfstoff VidPrevtyn Beta zur Auffrischimpfung von Personen≥ 18 Jahren derzeit nicht zu empfehlen | Vanessa Piechotta Judith Koch Christian Bogdan Gerd Burchard Edeltraut Garbe | 2023/2/23 | |
Wissenschaftliche Begründung der STIKO zur Implementierung der COVID-19-Impfung in die allgemeinen Empfehlungen der STIKO 2023 | Judith Koch Vanessa Piechotta Reinhard Berner Christian Bogdan Gerd Burchard | 2023/5/25 | |
Extracellular vesicles of the probiotic bacteria E. coli O83 activate innate immunity and prevent allergy in mice | Cell Communication and Signaling | Anna Marlene Schmid Agnieszka Razim Magdalena Wysmołek Daniela Kerekes Melissa Haunstetter | 2023/10/20 |
Wissenschaftliche Begründung der STIKO zur Aktualisierung der Empfehlung zur SARS-CoV-2-Prä-Expositionsprophylaxe mit Tixagevimab/Cilgavimab (Evusheld) | Agata Mikolajewska Kerstin Kling Vanessa Piechotta Judith Koch Gerd Burchard | 2023/2/23 | |
Spatial distribution of Her-2/neu and PD-L1 expression in lung metastases after active immunization with a Her-2/neu-targeting mimotope-based multipeptide B-cell vaccine in a … | Journal of Comparative Pathology | S Högler J Tobias P Kodajova M Drinic K Ambroz | 2023/5/1 |
1536P HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+ advanced stomach cancer-Dose … | Annals of Oncology | Joshua Tobias Michael Kundi E Garner-Spitzer Christoph Zielinski Marina Maglakelidze | 2023/10/1 |
HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2-overexpressing metastatic or advanced … | Marina Maglakelidze Dinara E Ryspayeva Zoran Andric Zoran Petrovic Iurie Bulat | 2023/2/1 | |
Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022 | Eurosurveillance | Angelika Wagner Joanna Jasinska Daniela Schmid Michael Kundi Ursula Wiedermann | 2023/4/27 |
472P Prevention of metastasis formation by combination therapy targeting Her2 and PD-L1 in Her2-expressing tumors based on observed efficacious vaccination against Her2 … | Annals of Oncology | J Tobias S Högler M Kundi D Shih-Cheih Lin Y Chao | 2023/10/1 |
The association of time of day of ChAdOx1 nCoV-19 vaccine administration with SARS-CoV-2 anti-spike IgG antibody levels: an exploratory observational study | Journal of Biological Rhythms | Astrid C Erber Angelika Wagner Marianna Karachaliou Maren Jeleff Polyxeni Kalafatis | 2023/2 |
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion | International Journal of Molecular Sciences | Joshua Tobias Sandra Högler Martin Raigel Diego Shih-Chieh Lin Yee Chao | 2023/12/24 |
